Effect of Cross-Sex Hormones on Body Composition, Bone Mineral Density, and Muscle Strength in Trans Women
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Cross-sex hormone therapy (CHT) changes the physical characteristics of transgender women to match their gender identity and expression. This study aimed to determine the effects of feminizing cross-sex hormones on body composition, bone mineral density (BMD) and muscle strength in transgender women. Methods: A prospective observational study assessed 11 participants who underwent feminizing CHT. Dual energy X-ray absorptiometry (DXA), and handgrip strength were measured before CHT and after 6-months of CHT. Fat mass, lean body mass (LBM), and BMD were measured by DXA and handgrip strength was measured by hand-dynamometer. Results: Regional body fat in the trunk, legs, and gynoid region increased by 18%, 27.4%, and 27.2%, respectively after 6 months of CHT. Total body fat increased by 16.2%, while the fat mass ratio decreased by 7.2%. Although body fat increased, the android/gynoid fat ratio decreased; BMD in the lumbar spine significantly increased by 3.9% (P=0.0051), but changes in the femoral neck (P=0.1969) and total femur (P=0.4769) were not significant. Changes in LBM ranged from -3% (trunk) to -8% (arm region). Right-hand grip strength also significantly decreased by 7.7% (P=0.0467). Conclusions: After 6 months of CHT, transgender women showed a general increase in fat mass and a decreased in overall LBM and handgrip strength. Increase in fat mass percentage were more remarkable in gynoid region, leading to a more “female” body fat distribution.
Abstract
Background: Cross-sex hormone therapy (CHT) changes the physical characteristics of transgender women to match their gender identity and expression. This study aimed to determine the effects of feminizing cross-sex hormones on body composition, bone mineral density (BMD) and muscle strength in transgender women. Methods: A prospective observational study assessed 11 participants who underwent feminizing CHT. Dual energy X-ray absorptiometry (DXA), and handgrip strength were measured before CHT and after 6-months of CHT. Fat mass, lean body mass (LBM), and BMD were measured by DXA and handgrip strength was measured by hand-dynamometer. Results: Regional body fat in the trunk, legs, and gynoid region increased by 18%, 27.4%, and 27.2%, respectively after 6 months of CHT. Total body fat increased by 16.2%, while the fat mass ratio decreased by 7.2%. Although body fat increased, the android/gynoid fat ratio decreased; BMD in the lumbar spine significantly increased by 3.9% (P=0.0051), but changes in the femoral neck (P=0.1969) and total femur (P=0.4769) were not significant. Changes in LBM ranged from -3% (trunk) to -8% (arm region). Right-hand grip strength also significantly decreased by 7.7% (P=0.0467). Conclusions: After 6 months of CHT, transgender women showed a general increase in fat mass and a decreased in overall LBM and handgrip strength. Increase in fat mass percentage were more remarkable in gynoid region, leading to a more “female” body fat distribution.
참고문헌 (25)
- Sam Winter, "Transgender people: health at the margins of society", The Lancet, 388(10042), pp.390~400 (2016), Elsevier BV[DOI]
- Joshua D. Safer, "Care of Transgender Persons", New England Journal of Medicine, 381(25), pp.2451~2460 (2019), Massachusetts Medical Society[DOI]
- Deutsch MB, "Updated recommendations from the world professional association for transgender health standards of care", Am Fam Physician, 87, pp.89~93 (2013)
- Hembree WC, "Endocrine treatment of gender-dysphoric", gender-incongruent persons: an Endocrine Society Clinical Practice Guideline, 2017, pp.102, 3869~3903
- Micol S. Rothman, "Bone Health in the Transgender Population", Clinical Reviews in Bone and Mineral Metabolism, 17(2), pp.77~85 (2019), Springer Science and Business Media LLC[DOI]
- M. Klaver, "Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis", Andrologia, 49(5), pp.e12660~ (2017), Wiley[DOI]
- "National health and nutrition examination survey: 2005-2006 Data documentation, codebook, and frequencies: Dual energy X-ray absorptiometry - Android/Gynoid (DXXAG_D)" (2013)[URL]
- 이승후, "Measurement and Interpretation of Handgrip Strength for Research on Sarcopenia and Osteoporosis", 대한골대사학회지, 27(2), pp.85~96 (2020), 대한골대사학회
- 이종석, "국민건강영양조사(2008-2011)를 활용한 골다공증 진단을 위한 정상 참고치와 유병률 연구", 통계연구, 18(2), pp.42~65 (2013), 통계청
- Bradley C. Nindl, "Gender differences in regional body composition and somatotrophic influences of IGF-I and leptin", Journal of Applied Physiology, 92(4), pp.1611~1618 (2002), American Physiological Society[DOI]
- Lapauw B, "Body composition, volumetric and areal bone parameters in male-to-female transsexual persons", Bone, 43, pp.1016~1021 (2008)[DOI]
- Katrien Wierckx, "Long‐Term Evaluation of Cross‐Sex Hormone Treatment in Transsexual Persons", The Journal of Sexual Medicine, 9(10), pp.2641~2651 (2012), Elsevier BV[DOI]
- I.R. Haraldsen, "Cross-sex pattern of bone mineral density in early onset gender identity disorder", Hormones and Behavior, 52(3), pp.334~343 (2007), Elsevier BV[DOI]
- Jonathan C.K. Wells, "Sexual dimorphism of body composition", Best Practice & Research Clinical Endocrinology & Metabolism, 21(3), pp.415~430 (2007), Elsevier BV[DOI]
- Harold N. Rosen, "Bone Densitometry in Transgender and Gender Non-Conforming (TGNC) Individuals: 2019 ISCD Official Position", Journal of Clinical Densitometry, 22(4), pp.544~553 (2019), Elsevier BV[DOI]
- E. Van Caenegem, "Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy", Bone, 54(1), pp.92~97 (2013), Elsevier BV[DOI]
- A. Mueller, "Body Composition and Bone Mineral Density in Male-to-Female Transsexuals During Cross-Sex Hormone Therapy Using Gonadotrophin-Releasing Hormone Agonist", Experimental and Clinical Endocrinology & Diabetes, 119(02), pp.95~100 (2011), Georg Thieme Verlag KG[DOI]
- Paul Van Kesteren, "Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones", Clinical Endocrinology, 48(3), pp.347~354 (1998), Wiley[DOI]
- P. Lips, "The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals", Journal of Bone and Mineral Research, 4(5), pp.657~662 (1989), Wiley[DOI]
- Tsuyoshi Miyajima, "A study of changes in bone metabolism in cases of gender identity disorder", Journal of Bone and Mineral Metabolism, 30(4), pp.468~473 (2012), Springer Science and Business Media LLC[DOI]
- S. Reutrakul, "The effects of oestrogen exposure on bone mass in male to female transsexuals", Clinical Endocrinology, 49(6), pp.811~814 (1998), Wiley[DOI]
- Naykky Singh-Ospina, "Effect of Sex Steroids on the Bone Health of Transgender Individuals: A Systematic Review and Meta-Analysis", The Journal of Clinical Endocrinology & Metabolism, 102(11), pp.3904~3913 (2017), The Endocrine Society[DOI]
- Miranda Scharff, "Change in grip strength in trans people and its association with lean body mass and bone density", Endocrine Connections, 8(7), pp.1020~1028 (2019), Bioscientifica[DOI]
- Brown M, "Skeletal muscle and bone: effect of sex steroids and aging", Adv Physiol Educ, 32, pp.120~126 (2008)[DOI]
- 임현혜, "Gender affirmative care of transgender people: a single center’s experience in Korea", Obstetrics & Gynecology Science, 62(1), pp.46~55 (2019), 대한산부인과학회[DOI]